Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-X-C chemokine receptor type 3
(Homo sapiens (Human)) | BDBM50371497
(CHEMBL437401)Show SMILES CCOc1ccc(cc1)-n1cc(nc1[C@@H](C)N(C[C@H]1CCCN1C)C(=O)Cc1ccc(F)c(c1)C(F)(F)F)-c1ccccc1 Show InChI InChI=1S/C34H36F4N4O2/c1-4-44-28-15-13-26(14-16-28)42-22-31(25-9-6-5-7-10-25)39-33(42)23(2)41(21-27-11-8-18-40(27)3)32(43)20-24-12-17-30(35)29(19-24)34(36,37)38/h5-7,9-10,12-17,19,22-23,27H,4,8,11,18,20-21H2,1-3H3/t23-,27-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Displacement of [125I]IP10 from human recombinant CXCR3 receptor expressed in IL2-activated human PBMC |
Bioorg Med Chem Lett 18: 608-13 (2008)
Article DOI: 10.1016/j.bmcl.2007.11.072 BindingDB Entry DOI: 10.7270/Q2668F1D |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 3
(Homo sapiens (Human)) | BDBM50371497
(CHEMBL437401)Show SMILES CCOc1ccc(cc1)-n1cc(nc1[C@@H](C)N(C[C@H]1CCCN1C)C(=O)Cc1ccc(F)c(c1)C(F)(F)F)-c1ccccc1 Show InChI InChI=1S/C34H36F4N4O2/c1-4-44-28-15-13-26(14-16-28)42-22-31(25-9-6-5-7-10-25)39-33(42)23(2)41(21-27-11-8-18-40(27)3)32(43)20-24-12-17-30(35)29(19-24)34(36,37)38/h5-7,9-10,12-17,19,22-23,27H,4,8,11,18,20-21H2,1-3H3/t23-,27-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Displacement of [125I]IP10 from human recombinant CXCR3 receptor expressed in IL2-activated human PBMC in presence of plasma |
Bioorg Med Chem Lett 18: 608-13 (2008)
Article DOI: 10.1016/j.bmcl.2007.11.072 BindingDB Entry DOI: 10.7270/Q2668F1D |
More data for this Ligand-Target Pair | |